vs
Side-by-side financial comparison of CODEXIS, INC. (CDXS) and HARTE HANKS INC (HHS). Click either name above to swap in a different company.
HARTE HANKS INC is the larger business by last-quarter revenue ($39.9M vs $38.9M, roughly 1.0× CODEXIS, INC.). CODEXIS, INC. runs the higher net margin — 24.7% vs 5.5%, a 19.1% gap on every dollar of revenue. On growth, CODEXIS, INC. posted the faster year-over-year revenue change (81.3% vs -15.4%). CODEXIS, INC. produced more free cash flow last quarter ($19.6M vs $-686.0K). Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs -6.4%).
Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.
Harte Hanks is a global marketing services company headquartered in Boston, Massachusetts. Harte Hanks services include analytics, strategy, marketing technology, creative services, digital marketing, customer care, direct mail, logistics, and fulfillment.
CDXS vs HHS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $38.9M | $39.9M |
| Net Profit | $9.6M | $2.2M |
| Gross Margin | 94.8% | — |
| Operating Margin | 27.1% | -0.3% |
| Net Margin | 24.7% | 5.5% |
| Revenue YoY | 81.3% | -15.4% |
| Net Profit YoY | 192.5% | — |
| EPS (diluted) | $0.13 | $0.30 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $38.9M | $39.9M | ||
| Q3 25 | $8.6M | $39.5M | ||
| Q2 25 | $15.3M | $38.6M | ||
| Q1 25 | $7.5M | $41.6M | ||
| Q4 24 | $21.5M | $47.1M | ||
| Q3 24 | $12.8M | $47.6M | ||
| Q2 24 | $8.0M | $45.0M | ||
| Q1 24 | $17.1M | $45.4M |
| Q4 25 | $9.6M | $2.2M | ||
| Q3 25 | $-19.6M | $-2.3M | ||
| Q2 25 | $-13.3M | $-335.0K | ||
| Q1 25 | $-20.7M | $-392.0K | ||
| Q4 24 | $-10.4M | — | ||
| Q3 24 | $-20.6M | $142.0K | ||
| Q2 24 | $-22.8M | $-27.8M | ||
| Q1 24 | $-11.5M | $-171.0K |
| Q4 25 | 94.8% | — | ||
| Q3 25 | 71.3% | — | ||
| Q2 25 | 86.3% | — | ||
| Q1 25 | 63.8% | — | ||
| Q4 24 | 83.0% | — | ||
| Q3 24 | 66.4% | — | ||
| Q2 24 | 56.6% | — | ||
| Q1 24 | 71.6% | — |
| Q4 25 | 27.1% | -0.3% | ||
| Q3 25 | -220.3% | 1.3% | ||
| Q2 25 | -83.9% | 0.1% | ||
| Q1 25 | -271.6% | -0.1% | ||
| Q4 24 | -34.2% | -3.3% | ||
| Q3 24 | -129.0% | 4.0% | ||
| Q2 24 | -284.9% | 3.0% | ||
| Q1 24 | -69.6% | 0.8% |
| Q4 25 | 24.7% | 5.5% | ||
| Q3 25 | -228.1% | -5.8% | ||
| Q2 25 | -86.6% | -0.9% | ||
| Q1 25 | -274.3% | -0.9% | ||
| Q4 24 | -48.4% | — | ||
| Q3 24 | -160.8% | 0.3% | ||
| Q2 24 | -285.2% | -61.8% | ||
| Q1 24 | -67.4% | -0.4% |
| Q4 25 | $0.13 | $0.30 | ||
| Q3 25 | $-0.22 | $-0.31 | ||
| Q2 25 | $-0.16 | $-0.05 | ||
| Q1 25 | $-0.25 | $-0.05 | ||
| Q4 24 | $-0.12 | $-0.31 | ||
| Q3 24 | $-0.29 | $0.02 | ||
| Q2 24 | $-0.32 | $-3.84 | ||
| Q1 24 | $-0.16 | $-0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $78.2M | $5.6M |
| Total DebtLower is stronger | $40.1M | — |
| Stockholders' EquityBook value | $50.5M | $20.5M |
| Total Assets | $147.8M | $91.8M |
| Debt / EquityLower = less leverage | 0.79× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $78.2M | $5.6M | ||
| Q3 25 | $58.7M | $6.5M | ||
| Q2 25 | $66.3M | $4.8M | ||
| Q1 25 | $59.8M | $9.0M | ||
| Q4 24 | $73.5M | $9.8M | ||
| Q3 24 | $90.3M | $5.9M | ||
| Q2 24 | $73.2M | $11.0M | ||
| Q1 24 | $85.5M | $11.5M |
| Q4 25 | $40.1M | — | ||
| Q3 25 | $39.7M | — | ||
| Q2 25 | $39.4M | — | ||
| Q1 25 | $29.2M | — | ||
| Q4 24 | $28.9M | — | ||
| Q3 24 | $28.6M | — | ||
| Q2 24 | $28.4M | — | ||
| Q1 24 | $28.1M | — |
| Q4 25 | $50.5M | $20.5M | ||
| Q3 25 | $38.5M | $19.9M | ||
| Q2 25 | $55.6M | $22.2M | ||
| Q1 25 | $49.6M | $21.4M | ||
| Q4 24 | $66.9M | $21.7M | ||
| Q3 24 | $73.4M | $21.0M | ||
| Q2 24 | $61.4M | $20.6M | ||
| Q1 24 | $79.3M | $20.0M |
| Q4 25 | $147.8M | $91.8M | ||
| Q3 25 | $124.0M | $92.7M | ||
| Q2 25 | $138.2M | $95.0M | ||
| Q1 25 | $128.9M | $100.6M | ||
| Q4 24 | $149.0M | $101.8M | ||
| Q3 24 | $148.2M | $108.1M | ||
| Q2 24 | $132.0M | $109.7M | ||
| Q1 24 | $149.6M | $113.4M |
| Q4 25 | 0.79× | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 0.71× | — | ||
| Q1 25 | 0.59× | — | ||
| Q4 24 | 0.43× | — | ||
| Q3 24 | 0.39× | — | ||
| Q2 24 | 0.46× | — | ||
| Q1 24 | 0.35× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $20.1M | $737.0K |
| Free Cash FlowOCF − Capex | $19.6M | $-686.0K |
| FCF MarginFCF / Revenue | 50.3% | -1.7% |
| Capex IntensityCapex / Revenue | 1.3% | 3.6% |
| Cash ConversionOCF / Net Profit | 2.09× | 0.33× |
| TTM Free Cash FlowTrailing 4 quarters | $-23.8M | $-4.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $20.1M | $737.0K | ||
| Q3 25 | $-7.7M | $3.2M | ||
| Q2 25 | $-18.0M | $-4.8M | ||
| Q1 25 | $-13.8M | $-818.0K | ||
| Q4 24 | $-16.5M | $4.0M | ||
| Q3 24 | $-13.0M | $-2.9M | ||
| Q2 24 | $-12.2M | $1.6M | ||
| Q1 24 | $-7.8M | $-5.7M |
| Q4 25 | $19.6M | $-686.0K | ||
| Q3 25 | $-7.9M | $2.2M | ||
| Q2 25 | $-20.5M | $-5.1M | ||
| Q1 25 | $-15.1M | $-923.0K | ||
| Q4 24 | $-18.2M | $3.4M | ||
| Q3 24 | $-14.0M | $-4.9M | ||
| Q2 24 | $-12.6M | $926.0K | ||
| Q1 24 | $-8.9M | $-6.2M |
| Q4 25 | 50.3% | -1.7% | ||
| Q3 25 | -91.7% | 5.5% | ||
| Q2 25 | -133.6% | -13.1% | ||
| Q1 25 | -199.6% | -2.2% | ||
| Q4 24 | -85.0% | 7.3% | ||
| Q3 24 | -109.0% | -10.2% | ||
| Q2 24 | -157.5% | 2.1% | ||
| Q1 24 | -52.2% | -13.7% |
| Q4 25 | 1.3% | 3.6% | ||
| Q3 25 | 2.1% | 2.5% | ||
| Q2 25 | 16.4% | 0.6% | ||
| Q1 25 | 16.7% | 0.3% | ||
| Q4 24 | 8.3% | 1.3% | ||
| Q3 24 | 7.8% | 4.0% | ||
| Q2 24 | 5.0% | 1.5% | ||
| Q1 24 | 6.6% | 1.2% |
| Q4 25 | 2.09× | 0.33× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -20.76× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CDXS
Segment breakdown not available.
HHS
| Fulfillment And Logistics Services | $17.3M | 43% |
| Customer Care | $13.7M | 34% |
| Other | $8.9M | 22% |
